Compare INO & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INO | LFVN |
|---|---|---|
| Founded | 1979 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.5M | 78.0M |
| IPO Year | 1999 | 1996 |
| Metric | INO | LFVN |
|---|---|---|
| Price | $1.10 | $6.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $6.75 | ★ $11.00 |
| AVG Volume (30 Days) | ★ 1.5M | 885.6K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.56% |
| EPS Growth | 54.18 | ★ 226.09 |
| EPS | N/A | ★ 0.30 |
| Revenue | $42,220,086.00 | ★ $203,204,000.00 |
| Revenue This Year | $20,156.19 | N/A |
| Revenue Next Year | $421.95 | N/A |
| P/E Ratio | ★ N/A | $20.67 |
| Revenue Growth | ★ 19.37 | 1.86 |
| 52 Week Low | $1.03 | $3.90 |
| 52 Week High | $2.86 | $15.00 |
| Indicator | INO | LFVN |
|---|---|---|
| Relative Strength Index (RSI) | 43.35 | 43.63 |
| Support Level | $1.03 | $5.67 |
| Resistance Level | $1.23 | $7.15 |
| Average True Range (ATR) | 0.05 | 1.03 |
| MACD | 0.01 | -0.26 |
| Stochastic Oscillator | 45.00 | 14.66 |
Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.